Accessibility
A+
A
A-
Information
Accessibility Statement
Site Colors Display
(* Modern browsers like Chrome & Firefox)
Normal Display
Adjusted for color blinded
Adjusted for hard vision
Close
Scheduling an appointment has never been easier. What works best for you?
Live Chat
Telephone
03-5305000
WhatsApp
03-5305000
Search
image/svg+xml
Search research
Orientation
Contact Us
Schedule appointment
About
About
About Us
Our Team
ARC
Available Technologies
For Researchers
For Researchers
Policies and operations
Incentive Programs
The Innovation Cycle
Submit Your Invention
Success Stories
Sparc
News
Contact Us
image/svg+xml
Search research
Orientation
Contact Us
Schedule appointment
Search
About
About Us
Our Team
ARC
Available Technologies
For Researchers
Policies and operations
Incentive Programs
The Innovation Cycle
Submit Your Invention
Success Stories
Sparc
News
Contact Us
TTO
/
Available Technologies
/ Therapeutics & Compositions
Therapeutics & Compositions
Composition comprising an RNA therapeutic targeting FAT10 and uses of same for treating disorders characterized by abnormal lipid accumulation
Inhibition of Thrombin for Treatment of Retinal Pathologies
OFF-THE-SHELF T-CELLS TARGETING COMMON VIRUSES (#2020007)
THE HORMONE KLOTHO: A NOVEL THERAPY FOR BREAST AND PANCREATIC CANCERS (#2011025)
USE OF BILE ACIDS AND BILE SALTS TO INHIBIT BACTERIAL CONJUGATION AND ACQUISITION OF ANTIBIOTIC RESISTANCE (#2015031)
Novel Compounds for the Treatment of Liver Fibrosis/Cirrhosis (#2016045)
MB3 AS A DIAGNOSTIC AND TREATMENT TARGET TO INHIBIT METASTASIS IN MEDULLOBLASTOMA (#2016053)
Novel compounds to treat antibiotic-resistant clinical isolated pathogens such as Staphylococcus aureus as well as, Enterococcus faecalis (VRE) and Acinetobacter baumannii (#2012029)
Novel PAR-1-based Therapeutic Compounds for Neuroinflammatory Diseases (#2011026)
MULTI-EPITOPE CITRULLINATED PEPTIDE FOR TREATMENT OF RHEUMATOID ARTHRITIS (#2012040)
